Resignation and Stock Vesting Agreement between Paul A. Brooke and Novirio Pharmaceuticals Limited

Contract Categories: Human Resources › Separation Agreements
Summary

Paul A. Brooke resigns immediately as a director and ends his consulting role with Novirio Pharmaceuticals Limited. The company agrees that, upon this termination, 60,000 Ordinary Shares previously subject to a Stock Restriction Agreement will become fully vested. Both parties acknowledge and accept these terms as of March 31, 2002.

Read More Arrow
EX-10.10 11 b42179npex10-10.txt LETTER AGREEMENT - PAUL BROOKE EXHIBIT 10.10 Paul A. Brooke 21 E. 90th Street, #14AB New York, New York 10128 March 31, 2002 Jean-Pierre Sommadossi, Ph.D. Novirio Pharmaceuticals Limited c/o Novirio Pharmaceuticals, Inc. 125 CambridgePark Drive Cambridge, MA 02140 Dear Jean-Pierre: This letter is inform you that I resign effective immediately as a director of Novirio Pharmaceuticals Limited and, as we have agreed, will terminate my service as a consultant to the Company. Please acknowledge your receipt of this letter and your agreement and acknowledgement that the 60,000 Ordinary Shares which are the subject of the Stock Restriction Agreement dated as of December 15, 2000 by and between Novirio and me will become vested in full as of the effective date of this termination of service. Very truly yours, /s/ Paul A. Brooke Paul A. Brooke Acknowledged and Agreed this 31st day of March 2002 NOVIRIO PHARMACEUTICALS LIMITED By: /s/ Jean-Pierre Sommadossi ------------------------------------ Jean-Pierre Sommadossi, Ph.D. Chairman and Chief Executive Officer